KBC Group’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$80K Hold
18,658
– – ﹤0.01% 1522
2026
Q2
$98K Hold
18,658
– – ﹤0.01% 1431
2026
Q1
$33K Hold
18,658
– – ﹤0.01% 1776
2025
Q4
$44K Hold
18,658
– – ﹤0.01% 1669
2025
Q3
$57K Hold
18,658
– – ﹤0.01% 1599
2025
Q2
$52K Hold
18,658
– – ﹤0.01% 1593
2025
Q1
$67K Hold
18,658
– – ﹤0.01% 1700
2024
Q4
$59K Hold
18,658
– – ﹤0.01% 1781
2024
Q3
$53K Buy
+18,658
New +$42.7K ﹤0.01% 1683

Other funds holding CLOV

KBC Group's CLOV Position: Q3 2026 in Review

KBC Group held its Clover Health Investments (CLOV) position steady in Q3 2026 at 18,658 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #1522.

KBC Group first reported a position in CLOV in Q3 2024 and has held it in 9 quarters since. The position peaked at $98K in Q2 2026. 51 funds tracked by Wall St. Rank hold CLOV as of Q3 2026.

  • KBC Group held 18,658 shares of Clover Health Investments worth $80K as of Q3 2026.
  • KBC Group left its Clover Health Investments share count unchanged in Q3 2026.
  • Clover Health Investments made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1522 holding.
  • KBC Group first reported a position in Clover Health Investments in Q3 2024 and has held it in 9 quarters since.
  • KBC Group's Clover Health Investments position peaked at $98K in Q2 2026.
  • 51 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.